Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133704) titled 'The efficacy and safety of cryoablation combined with hepatic arterial infusion of iparomlimab and tuvonralimab (QL1706), intravenous dacarbazine, and oral lenvatinib in patients with liver metastases' on Sept. 30.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
hepatic metastases from malignant melanoma / liver metastases of malignant melanoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-01
Target Sample Size: Experimental Group:28;
Countries of Recruitment:
China
To know more, visit https://...